Observing People With Desmoid-Type Fibromatosis

Part of paid clinical trials in New York, New York.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT04281381
Status
Recruiting
Apply to this trial

Conditions

  • Desmoid Fibromatosis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Cross-sectional imaging — DIAGNOSTIC_TEST
    MRI with gadolinium contrast will be the imaging modality of choice. In patients with contraindications to MRI who instead undergo baseline evaluation by CT scan, tumor evaluation will be by serial CT scans with IV contrast throughout the study period.

Study Details

The purpose of this study is to closely observe people with desmoid-type fibromatosis over 1 months.

Key Dates

Start date
Feb 19, 2020
Status verified
May 2026
Primary completion
Feb 19, 2027
Completion
Feb 19, 2027

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Desmoid Fibromatosis
    Participants will have a clinical diagnosis of desmoid fibromatosis, either new or newly recurrent

Primary Outcome Measure

Progression free survival [ Time Frame: 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Memorial Sloan Kettering Cancer CenterNew YorkNew York10065
Aimee M Crago, MD, PhD
212-639-4807

Find similar trials in New York, NY

By research site
Memorial Sloan Kettering Cancer Center· New York, NY

Related Studies